Loading

Spotlight: Can the production of iPSC-derived beta islets for Type I diabetes be scaled up to be commercially viable?

19 Jan 2027
Theatre 2
Manufacturing, CMC and Supply Chain
Speakers
Dr Greg Russotti, Chief Technology & Manufacturing Officer - Century Therapeutics

Topic

CDMO CRO & Partnering,Cell Therapy ,Manufacturing CMC & Supply Chain

Persona

Biotech,Logistics & Distribution Partners,Pharma,Service Providers (CDMOs CROs & Suppliers),Tools tech & equipment providers